Prednisone Dosing Guidelines

Introduction to Prednisone Dosing

The typical dose for a 5-day course of prednisone is 40-60 mg daily, which can be tapered over the 5 days or maintained at the same dose throughout the course, depending on the condition being treated, as recommended by medical guidelines 1

For autoimmune hepatitis, initial dosing typically starts at 30-60 mg daily (considered low-dose) or can be higher at 60 mg daily (monotherapy) or 30 mg daily (when combined with azathioprine), with subsequent tapering, according to the American Association for the Study of Liver Diseases 2
For pemphigus vulgaris, a moderate approach is recommended with initial doses of 40-60 mg daily for mild disease and 60-100 mg daily for more severe cases, as suggested by the British Association of Dermatologists 3

When tapering is needed from doses of 20 mg or higher, reduction by 5 mg every week until reaching 10 mg/day, then further reduction by 2.5 mg/week down to 5 mg daily is recommended, based on guidelines from the American Association for the Study of Liver Diseases 2
For pemphigus vulgaris, once remission is achieved, dose can be cautiously tapered with an initial reduction of 5-10 mg weekly, and more slowly below 20 mg daily, as recommended by the British Association of Dermatologists 3

Combination therapy with azathioprine (prednisone 30 mg daily plus azathioprine 50 mg daily) has fewer corticosteroid-related side effects (10%) compared to higher-dose prednisone monotherapy (44%), according to the American Association for the Study of Liver Diseases 2
Hypothalamic-pituitary-adrenal axis suppression should be anticipated in patients receiving more than 7.5 mg of prednisolone equivalent daily for more than 3 weeks, as warned by the European League Against Rheumatism 4
Common side effects with short-term use include increased appetite, mood changes, and insomnia, while long-term use can lead to more serious effects including osteoporosis, hypertension, and diabetes, as reported by the European League Against Rheumatism 4